REQUEST A DEMO
Total
USD $0.00
Search more companies

Gene Planet Poland Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Gene Planet Poland Sp. z o.o. Profile Updated: September 03, 2021
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Gene Planet Poland Sp. z o.o. is an enterprise based in Poland. Its main office is in Warsaw. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The enterprise was incorporated on February 20, 2019. From the latest financial highlights, Gene Planet Poland Sp. z o.o. reported a net sales revenue drop of 11.69% in 2023. Its’ total assets recorded a negative growth of 7.74%. In 2023, Gene Planet Poland Sp. z o.o.’s net profit margin decreased by 3.38%.

Headquarters
Ul. Pulawska 12/3
Warsaw; Mazowieckie; Postal Code: 02-566

Contact Details: Purchase the Gene Planet Poland Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Gene Planet Poland Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Gene Planet Poland Sp. z o.o. report to view the information.
Incorporation Date:
February 20, 2019
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Gene Planet Poland Pro Sp. z o.o.
100%
Company Performance
Financial values in the chart are available after Gene Planet Poland Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-11.69%
Total operating revenue
-10.22%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-85.31%
Total assets
-7.74%
Total equity
4.07%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-3.38%
Return on Equity (ROE)
23.46%
Debt to Equity Ratio
69.33%
Quick Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?